TrialAnnals of surgical oncology2020

Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer.

Pranav Murthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.